Paper7591963
Cytotoxic activity of CD4+ T cells against autologous tumor cells.
Konomi Y and 4 others. Jpn J Cancer Res, 1995. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cytotoxic activity of CD4+ T cells against autologous tumor cells. Papers, record 7591963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7591963
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| Immunotherapy, Adoptive | Major topic |
| Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| CD4-CD8 Ratio | |
| CD8-Positive T-Lymphocytes | |
| Chromium | |
| Chromium Radioisotopes | |
| Colorimetry | |
| Cytotoxicity, Immunologic | |
| Female | |
| Gentian Violet | |
| Humans | |
| Lymphocytes, Tumor-Infiltrating | |
| Male | |
| Middle Aged |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3259261 | Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3259261 | PubMed |
| 2 | 215560 | Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. | Int J Cancer | 1979 | https://conductscience.org/library/papers/215560 | PubMed |
| 3 | 2795092 | Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2. | J Biol Response Mod | 1989 | https://conductscience.org/library/papers/2795092 | PubMed |
| 4 | 3262710 | Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. | J Exp Med | 1988 | https://conductscience.org/library/papers/3262710 | PubMed |
| 5 | 1593137 | The use of [35S]methionine as a target cell label in long term cytotoxic assays. | J Immunol Methods | 1992 | https://conductscience.org/library/papers/1593137 | PubMed |
| 6 | 6862692 | Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. | Int J Cancer | 1983 | https://conductscience.org/library/papers/6862692 | PubMed |
| 7 | 2437237 | Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. | J Exp Med | 1987 | https://conductscience.org/library/papers/2437237 | PubMed |
| 8 | 3158702 | Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. | J Immunol | 1985 | https://conductscience.org/library/papers/3158702 | PubMed |
| 9 | 1979348 | Separation and growth of human CD4+ and CD8+ tumor-infiltrating lymphocytes and peripheral blood mononuclear cells by direct positive panning on covalently attached monoclonal antibody-coated flasks. | J Biol Response Mod | 1990 | https://conductscience.org/library/papers/1979348 | PubMed |
| 10 | 7507026 | Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS). | Cytometry | 1993 | https://conductscience.org/library/papers/7507026 | PubMed |
| 11 | 1371532 | A new method for detachment of Dynabeads from positively selected B lymphocytes. | J Immunol Methods | 1992 | https://conductscience.org/library/papers/1371532 | PubMed |
| 12 | 8513449 | Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8513449 | PubMed |
| 13 | 1970108 | Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. | Lancet | 1990 | https://conductscience.org/library/papers/1970108 | PubMed |
| 14 | 8218952 | A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. | Biomed Pharmacother | 1993 | https://conductscience.org/library/papers/8218952 | PubMed |
| 15 | 8348560 | Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8348560 | PubMed |
| 16 | 6198422 | Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. | J Exp Med | 1984 | https://conductscience.org/library/papers/6198422 | PubMed |
| 17 | 6602860 | Clonal analysis of cytotoxic T cell response against human melanoma. | J Exp Med | 1983 | https://conductscience.org/library/papers/6602860 | PubMed |
| 18 | 8392912 | Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8392912 | PubMed |
| 19 | 3264384 | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3264384 | PubMed |
| 20 | 3100623 | Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. | J Immunol | 1987 | https://conductscience.org/library/papers/3100623 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 31285957 | Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinoma. | Am J Cancer Res | 2019 | https://conductscience.org/library/papers/31285957 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7591963
GET https://conductscience.org/api/papers/v1/7591963/references?page=2